Lyne Gagnon
- PBI-compound, a novel first-in-class anti-inflammatory/fibrotic compound, reduces bleomycin-induced pulmonary fibrosis by regulating inflammatory cytokines in bronchoalveolar fluidBy Brigitte Grouix, François Sarra-Bournet, Mikaël Tremblay, André Doucet, Pierre Laurin and Lyne GagnonBrigitte Grouix1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaFrançois Sarra-Bournet1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaMikaël Tremblay1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaAndré Doucet1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaPierre Laurin1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaLyne Gagnon1Biology, ProMetic BioSciences Inc., Laval, QC, Canada
- PBI-compound, a novel first-in-class anti-fibrotic compound, inhibits CTGF and collagen production in murine and human fibroblasts, and reduces lung fibrosis in the bleomycin-induced lung fibrosis modelBy Martin Leduc, Brigitte Grouix, Liette Gervais, François Sarra-Bournet, Mikaël Tremblay, Pierre Laurin and Lyne GagnonMartin Leduc1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaBrigitte Grouix1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaLiette Gervais1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaFrançois Sarra-Bournet1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaMikaël Tremblay1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaPierre Laurin1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaLyne Gagnon1Biology, ProMetic BioSciences Inc., Laval, QC, Canada
- PBI-compound, a novel first-in-class anti-inflammatory/fibrotic compound, reduces bleomycin-induced idiopathic pulmonary fibrosis by regulation of extracellular matrix remodellingBy Lyne Gagnon, François Sarra-Bournet, Mikaël Tremblay, André Doucet, Alexandra Felton, Martin Leduc, Pierre Laurin and Brigitte GrouixLyne Gagnon1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaFrançois Sarra-Bournet1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaMikaël Tremblay1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaAndré Doucet1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaAlexandra Felton1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaMartin Leduc1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaPierre Laurin1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaBrigitte Grouix1Biology, ProMetic BioSciences Inc., Laval, QC, Canada
- PBI-compound, a novel first-in-class anti-fibrotic compound, reduces lung fibrosis in the bleomycin-induced lung fibrosis model: A comparative study with pirfenidoneBy Lyne Gagnon, Mikaël Tremblay, François Sarra-Bournet, Liette Gervais, Shaun Abbott, Jean-Simon Duceppe, Boulos Zacharie, Christopher Penney, Pierre Laurin and Brigitte GrouixLyne Gagnon1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaMikaël Tremblay1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaFrançois Sarra-Bournet1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaLiette Gervais1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaShaun Abbott1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaJean-Simon Duceppe1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaBoulos Zacharie1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaChristopher Penney1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaPierre Laurin1Biology, ProMetic BioSciences Inc., Laval, QC, CanadaBrigitte Grouix1Biology, ProMetic BioSciences Inc., Laval, QC, Canada
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
